0001402051-22-000002.txt : 20220708 0001402051-22-000002.hdr.sgml : 20220708 20220708160434 ACCESSION NUMBER: 0001402051-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220707 FILED AS OF DATE: 20220708 DATE AS OF CHANGE: 20220708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis William CENTRAL INDEX KEY: 0001402051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 221074404 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE STREET 2: BUILDING 10 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wf-form4_165731066077799.xml FORM 4 X0306 4 2022-07-07 0 0001104506 INSMED Inc INSM 0001402051 Lewis William 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 1 1 0 0 Chair and CEO Common Stock 2022-07-07 4 M 0 96614 16.16 A 353330 D Common Stock 2022-07-07 4 S 0 96614 23 D 256716 D Stock Option (right to buy) 16.16 2022-07-07 4 M 0 96614 0 D 2026-01-07 Common Stock 96614.0 0 D The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan. This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. /s/ William H. Lewis, by Michael Smith as Attorney in Fact 2022-07-08